TABLE 2.
Treatment and outcomes of t(4;12) patients
| n (%) | ||
|---|---|---|
| Total | 21 | |
| Overall survival | ||
| Median (95% CI), months | 7.8 (3–23) | |
| Antitumoral therapies | 16/21 (76) | |
| Induction therapy | 5/16 (31) | |
| Hypomethylating agents | 5/16 (31) | |
| Others | 6/16 (38) | |
| Response | ||
| ORR | 6/16 (38) | |
| PR | 1/16 (7) | |
| CR | 5/16 (31) | |
| Induction chemotherapy | ||
| ORR | 2/5 (40) | |
| CR | 2/5 (40) | |
| Refractory | 3/5 (60) | |
| Hypomethylating agents | ||
| ORR | 4/5 (80) | |
| PR | 3/5 (60) | |
| CR | 1/5 (20) | |
| Refractory | 1/5 (20) | |
| Others | ||
| ORR | 0/6 | |
Abbreviations: CI, confidence interval; CR, complete remission; ORR, overall response rate; PR, partial response.